Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Cytek Biosciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 125 | 1 | 129 | +5 |
| Shares | 80.6M | 93.5K | 76.2M | −4.32M (−5.4%) |
| Value | $540.9M | $627.3K | $425.1M | −$115.2M (−21.3%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Cytek Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 233,900 | $1.31M | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 155,759 | $869.1K | 0.01% |
| Trexquant Investment LP | 138,394 | $772.2K | 0.01% |
| EntryPoint Capital, LLC | 99,036 | $552.6K | 0.26% |
| Corebridge Financial, Inc. | 69,330 | $386.9K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 61,826 | $345.0K | 0.00% |
| Citadel Advisors LLC | 57,128 | $318.8K | 0.00% |
| Allianz Asset Management GmbH | 37,400 | $208.7K | 0.00% |
| ExodusPoint Capital Management, LP | 37,034 | $207.0K | 0.00% |
| Natixis Advisors, L.P. | 35,951 | $201.0K | 0.00% |
| SG Americas Securities, LLC | 32,333 | $180.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 25,144 | $140.3K | 0.00% |
| Gsa Capital Partners LLP | 14,647 | $82.0K | 0.01% |
| Verition Fund Management LLC | 13,757 | $76.8K | 0.00% |
| SlateStone Wealth, LLC | 12,500 | $70.0K | 0.01% |
| Cerity Partners LLC | 11,815 | $65.9K | 0.00% |
| Clear Street Markets LLC | 878 | $5.00K | 0.00% |
| Smartleaf Asset Management LLC | 526 | $2.89K | 0.00% |
| Advisor Group Holdings, Inc. | 89 | $497 | 0.00% |
| Huntington National Bank | 36 | $201 | 0.00% |
| Larson Financial Group LLC | 24 | $134 | 0.00% |
Sold out (16)
Institutions that held Cytek Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Ra Capital Management, L.P. | 6,809,404 | $45.7M |
| Divisadero Street Capital Management, LP | 487,550 | $3.27M |
| Texas Permanent School Fund | 86,601 | $581.1K |
| Marshall Wace, LLP | 68,591 | $460.2K |
| American International Group, Inc. | 64,321 | $431.6K |
| Mirae Asset Global Investments Co., Ltd. | 49,053 | $421.4K |
| Grandeur Peak Global Advisors, LLC | 33,131 | $222.3K |
| XTX Topco Ltd | 19,844 | $133.2K |
| Graham Capital Management, L.P. | 15,379 | $103.2K |
| Oxford Asset Management LLP | 13,726 | $92.1K |
| Two Sigma Investments, LP | 13,211 | $88.6K |
| Group One Trading, L.P. | 8,377 | $56.2K |
| Metropolitan Life Insurance Co | 6,522 | $43.8K |
| KBC Group NV | 3,884 | $26.0K |
| Leonteq Securities AG | 1,090 | $7.31K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 24 | $161 |
Not filed for Q2 2024 yet (1)
Institutions that held Cytek Biosciences, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 93,492 | $627.3K |